by Csequence | Sep 8, 2022 | Communications, Weekly Cannabis News, Weekly News
Weekly Cannabis News September 2nd – September 9th, 2022 Cannabidiol (CBD) & Anxiogenic/Compulsive Behaviors Following a High-Carbohydrate (HC) Diet The study showed that sub-chronic CBD treatment attenuated the compulsive and anxiogenic-like behaviors...
by Csequence | Sep 2, 2022 | Communications, Weekly Cannabis News
Weekly Cannabis News August 26th – September 2nd, 2022 Effects of Δ9-Tetrahydrocannabinol (Δ9-THC) & Cannabidiol (CBD) on Salivation Results from animal studies showed that Δ9-THC, but not CBD treatment reduced basal salivation. However, CBD did reverse the...
by Csequence | Aug 30, 2022 | Communications, Weekly Cannabis News
Weekly Cannabis News August 19th – August 26th, 2022 Low ∆9-Tetrahydrocannabinol (∆9-THC) Cannabis Oil for Fibromyalgia (FM) Treatment Study results showed that this cannabis extract was effective in reversing FM symptoms in a mouse model. Fibromyalgia (FM) is a...
by Csequence | Aug 19, 2022 | Communications, Weekly Cannabis News
Weekly Cannabis News August 12th – August 19th, 2022 Post-Traumatic Stress Disorder (PTSD) & Cannabis Use During COVID-19 Individuals who reported an increase in cannabis consumption during the pandemic displayed worsening depressive symptoms, a new study...
by Csequence | Aug 11, 2022 | Communications, Weekly Cannabis News
Weekly Cannabis News August 5th – August 12th, 2022 Cannabis Use & COVID-19 Symptoms Severity COVID-19 cannabis consumers reported better clinical outcomes compared to non-consumers, suggesting the need for additional investigations. The novel severe acute...
by Csequence | Aug 11, 2022 | Communications, Weekly Cannabis News
August 5th – August 12th, 2022 Cannabis Use & COVID-19 Symptoms Severity COVID-19 cannabis consumers reported better clinical outcomes compared to non-consumers, suggesting the need for additional investigations. The novel severe acute respiratory syndrome...
Some text her explaining our event planning services.
For more info, contact us:
events@csequence.com